CL2008002653A1 - Asociacion que comprende un compuesto de terutroban y un inhibidor de la enzima de conversion de la angiotensiva; composicion farmaceutica que comprende como principio activo la asociacion de compuestos antes mencionada; uso de la asociacion para preparar un medicamento destinado a tratar complicaciones. - Google Patents
Asociacion que comprende un compuesto de terutroban y un inhibidor de la enzima de conversion de la angiotensiva; composicion farmaceutica que comprende como principio activo la asociacion de compuestos antes mencionada; uso de la asociacion para preparar un medicamento destinado a tratar complicaciones.Info
- Publication number
- CL2008002653A1 CL2008002653A1 CL2008002653A CL2008002653A CL2008002653A1 CL 2008002653 A1 CL2008002653 A1 CL 2008002653A1 CL 2008002653 A CL2008002653 A CL 2008002653A CL 2008002653 A CL2008002653 A CL 2008002653A CL 2008002653 A1 CL2008002653 A1 CL 2008002653A1
- Authority
- CL
- Chile
- Prior art keywords
- association
- terutroban
- prepare
- compounds
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Asociación que comprende un inhibidor de la enzima de conversión de la angiotensina y un compuesto de terutroban; composición farmacéutica que comprende como principio activo la asociación de compuestos antes mencionado; uso de la asociación para preparar un medicamento para tratar complicaciones vasculares.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0706345A FR2920772B1 (fr) | 2007-09-11 | 2007-09-11 | Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008002653A1 true CL2008002653A1 (es) | 2009-06-05 |
Family
ID=39366989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008002653A CL2008002653A1 (es) | 2007-09-11 | 2008-09-08 | Asociacion que comprende un compuesto de terutroban y un inhibidor de la enzima de conversion de la angiotensiva; composicion farmaceutica que comprende como principio activo la asociacion de compuestos antes mencionada; uso de la asociacion para preparar un medicamento destinado a tratar complicaciones. |
Country Status (27)
Country | Link |
---|---|
US (1) | US20090075976A1 (es) |
EP (1) | EP2036886A1 (es) |
JP (1) | JP2009067793A (es) |
KR (1) | KR20090027167A (es) |
CN (1) | CN101385723A (es) |
AP (1) | AP2008004590A0 (es) |
AR (1) | AR068385A1 (es) |
AU (1) | AU2008207584A1 (es) |
BR (1) | BRPI0804140A2 (es) |
CA (1) | CA2638354A1 (es) |
CL (1) | CL2008002653A1 (es) |
CO (1) | CO6020018A1 (es) |
CR (1) | CR10228A (es) |
EA (1) | EA200801829A1 (es) |
EC (1) | ECSP088713A (es) |
FR (1) | FR2920772B1 (es) |
GT (2) | GT200800169A (es) |
IL (1) | IL193585A0 (es) |
MA (1) | MA30374B1 (es) |
MX (1) | MX2008011329A (es) |
NZ (1) | NZ571144A (es) |
PA (1) | PA8795401A1 (es) |
PE (1) | PE20090941A1 (es) |
SG (1) | SG151171A1 (es) |
TW (1) | TW200920354A (es) |
UY (1) | UY31304A1 (es) |
WO (1) | WO2009066035A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012015944A2 (en) | 2010-07-29 | 2012-02-02 | The Trustees Of The University Of Pennsylvania | Novel tetrahydronaphalene antagonists to the thromboxane a2 (tp) receptor |
CN109248319A (zh) * | 2017-07-14 | 2019-01-22 | 郜建敏 | 含有司坦类化合物和阿司匹林的药物组合物 |
KR102659451B1 (ko) * | 2018-09-18 | 2024-04-23 | 일라이 릴리 앤드 캄파니 | 트레프로스티닐의 에르부민 염 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2711139B1 (fr) * | 1993-10-15 | 1995-12-01 | Adir | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
US6509348B1 (en) * | 1998-11-03 | 2003-01-21 | Bristol-Myers Squibb Company | Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination |
FR2838057B1 (fr) * | 2002-04-05 | 2005-07-08 | Servier Lab | Nouvelle association d'un antithrombotique et d'aspirine |
FR2857593B1 (fr) * | 2003-07-18 | 2005-10-14 | Servier Lab | Composition pharmaceutique orodispersible d'un compose antithrombotique |
FR2860436B1 (fr) * | 2003-10-03 | 2006-01-20 | Servier Lab | Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire |
FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
-
2007
- 2007-09-11 FR FR0706345A patent/FR2920772B1/fr not_active Expired - Fee Related
-
2008
- 2008-08-19 PE PE2008001404A patent/PE20090941A1/es not_active Application Discontinuation
- 2008-08-20 SG SG200806159-0A patent/SG151171A1/en unknown
- 2008-08-20 CR CR10228A patent/CR10228A/es not_active Application Discontinuation
- 2008-08-21 IL IL193585A patent/IL193585A0/en unknown
- 2008-08-21 UY UY31304A patent/UY31304A1/es unknown
- 2008-08-26 AP AP2008004590A patent/AP2008004590A0/xx unknown
- 2008-08-28 AU AU2008207584A patent/AU2008207584A1/en not_active Abandoned
- 2008-09-02 GT GT200800169A patent/GT200800169A/es unknown
- 2008-09-02 TW TW097133649A patent/TW200920354A/zh unknown
- 2008-09-03 EC EC2008008713A patent/ECSP088713A/es unknown
- 2008-09-04 MX MX2008011329A patent/MX2008011329A/es not_active Application Discontinuation
- 2008-09-05 GT GT200800178A patent/GT200800178A/es unknown
- 2008-09-08 MA MA31217A patent/MA30374B1/fr unknown
- 2008-09-08 US US12/231,981 patent/US20090075976A1/en not_active Abandoned
- 2008-09-08 CL CL2008002653A patent/CL2008002653A1/es unknown
- 2008-09-09 AR ARP080103905A patent/AR068385A1/es not_active Application Discontinuation
- 2008-09-09 PA PA20088795401A patent/PA8795401A1/es unknown
- 2008-09-09 JP JP2008230403A patent/JP2009067793A/ja active Pending
- 2008-09-10 BR BRPI0804140-7A patent/BRPI0804140A2/pt not_active IP Right Cessation
- 2008-09-10 EP EP08290847A patent/EP2036886A1/fr not_active Withdrawn
- 2008-09-10 KR KR1020080089346A patent/KR20090027167A/ko not_active Application Discontinuation
- 2008-09-10 CA CA002638354A patent/CA2638354A1/fr not_active Abandoned
- 2008-09-10 NZ NZ571144A patent/NZ571144A/en not_active IP Right Cessation
- 2008-09-10 EA EA200801829A patent/EA200801829A1/ru unknown
- 2008-09-10 WO PCT/FR2008/001261 patent/WO2009066035A2/fr active Application Filing
- 2008-09-11 CN CNA2008102135510A patent/CN101385723A/zh active Pending
- 2008-09-11 CO CO08095778A patent/CO6020018A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20090941A1 (es) | 2009-07-18 |
BRPI0804140A2 (pt) | 2009-06-16 |
GT200800178A (es) | 2010-07-02 |
TW200920354A (en) | 2009-05-16 |
KR20090027167A (ko) | 2009-03-16 |
JP2009067793A (ja) | 2009-04-02 |
AU2008207584A1 (en) | 2009-03-26 |
PA8795401A1 (es) | 2009-04-23 |
CN101385723A (zh) | 2009-03-18 |
MX2008011329A (es) | 2009-03-10 |
AR068385A1 (es) | 2009-11-11 |
CR10228A (es) | 2009-04-28 |
US20090075976A1 (en) | 2009-03-19 |
FR2920772B1 (fr) | 2009-10-23 |
EA200801829A1 (ru) | 2009-06-30 |
GT200800169A (es) | 2010-05-21 |
FR2920772A1 (fr) | 2009-03-13 |
EP2036886A1 (fr) | 2009-03-18 |
CA2638354A1 (fr) | 2009-03-11 |
NZ571144A (en) | 2010-01-29 |
WO2009066035A2 (fr) | 2009-05-28 |
AP2008004590A0 (en) | 2008-08-31 |
ECSP088713A (es) | 2008-10-31 |
UY31304A1 (es) | 2008-09-30 |
WO2009066035A3 (fr) | 2009-08-27 |
CO6020018A1 (es) | 2009-03-31 |
IL193585A0 (en) | 2011-08-01 |
SG151171A1 (en) | 2009-04-30 |
MA30374B1 (fr) | 2009-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20120283A (es) | Inhibidor de bromodominio de benzodiazepina | |
ECSP11011526A (es) | Aril-piridinas como inhibidoras de sintasa de aldosterona | |
BRPI0917017B8 (pt) | inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos | |
CL2012003281A1 (es) | Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica. | |
CL2011000214A1 (es) | Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona. | |
BRPI0721905B8 (pt) | composto inibidor de proteassoma, sua composição farmacêutica e seu uso | |
CO7160059A2 (es) | Formulación líquida | |
CL2012000248A1 (es) | Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina. | |
EA201200550A1 (ru) | Фармацевтические композиции, включающие bi-1356 и метформин | |
CO6351742A2 (es) | Compuestos organicos para la cicatrizacion de heridas | |
SV2010003674A (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa | |
NI201000189A (es) | Formulación de medicamento sólido con liberación retardadas. | |
CL2008002049A1 (es) | Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
CL2011000258A1 (es) | Compuestos derivados de fenilamino-isonicotinamida; inhibidores de mek; composicion farmaceutica y uso para el tratamiento de enfermedades hiperproliferativas tales como cancer e inflamacion. | |
CL2011001026A1 (es) | Uso de pimobedan para preparar un medicamento util en el tratamiento de cardiomiopatia hipertrofica en un gato. | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
CL2008000683A1 (es) | Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de la enzima de conversion de angiotensina (ace); formulacion de dosis unitaria; y uso en el tratamiento de la diabetes. | |
CL2008002653A1 (es) | Asociacion que comprende un compuesto de terutroban y un inhibidor de la enzima de conversion de la angiotensiva; composicion farmaceutica que comprende como principio activo la asociacion de compuestos antes mencionada; uso de la asociacion para preparar un medicamento destinado a tratar complicaciones. | |
CL2007000485A1 (es) | Sal de alisquereno; procedimiento de preparacion; composicion farmaceutica que comprende a dicha sal; y uso del compuesto para el tratamiento de enfermedades que puedan ser moduladas mediante la inhibicion de la renina. | |
CL2008002555A1 (es) | Composicion farmaceutica que comprende un compuesto de levosimendan y un segundo ingrediente activo un antagonista del receptor de angiotensiva ii; un kit farmaceutico que comprende dicha composicion; y su uso para la prevencion o la inhibicion de apoplejia. | |
ECSP12012332A (es) | Asociación de inhibidores de la xantina oxidasa y la instatina y su uso | |
BR112012031289A2 (pt) | novos derivados 1,4-diazepanos, inibidores de pde-5 | |
EA201170950A1 (ru) | Новая комбинация активных ингредиентов, содержащая нестероидное противовоспалительное лекарственное средство и производное колхикозида | |
CL2009001493A1 (es) | Compuestos derivados de 3-cianopirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de infecciones bacterianas. | |
AR059081A1 (es) | Composicion farmaceutica estable de carisoprodol y meloxicam |